Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in WM and related lymphoid neoplasms

Key Findings

• ●MYD88 L265P detected in 100% of WM patients using AS-PCR
• ●Present in 47% of IgM-MGUS, 6% of SMZL, 4% of B-CLPD
• ●Represents a molecular hallmark of WM

Referenced in (1 disease)

No validation events recorded yet. Source will be checked on the next kipine-source-validator run.